$BIOX

Bioceres (BIOX) Q4 2026 Earnings Call Transcript

Bioceres (BIOX) reported a challenging fiscal year 2026 with an 18% revenue decline to $238M, driven by seed business reconfiguration and lower crop protection performance. Quarterly revenue was $55.9M, with crop nutrition revenue growing 36%. Adjusted EBITDA improved to $600K from a $9.6M loss, aided by a 19% reduction in SG&A expenses. The company faces litigation and debt restructuring challenges, with total financial debt at $225.9M. Management targets a 40% gross margin for fiscal 2027 and

Original reporting
Published Sep 15, 2026, 4:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 5:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Bioceres (BIOX) Q4 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$BIOXNeutralMed
01

Why it matters

The earnings release provides fresh guidance on profitability and debt, offering traders new data to reassess valuation.

02

Market read

Earnings data introduces material new information for BIOX investors, with mixed signals on growth and financial health.

03

What to watch

Potential upside from microbeaded fertilizer growth and upcoming Brazil market expansion.

Relevance 7/10Novelty 7/10Timing: post-earnings release

Background

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) reported its fiscal Q4 2026 and full‑year results, detailing revenue trends, margin changes, and debt restructuring.

Company-level read

Ticker impact

$BIOXNeutralMedium confidence
Context

Q4 2026 earnings release shows revenue down 18% YoY, adjusted EBITDA turning positive, and debt restructuring in Argentina.

Expected impact

Potential modest upside if investors focus on EBITDA improvement; downside if revenue decline dominates.

Evidence & confidence

Positive EBITDA swing offsets revenue weakness, but elevated debt and litigation risk limit upside.

Market effects

Highlights challenges in agri‑tech seed segment and potential shift toward crop‑nutrition products.

Debt restructuring in Argentina may affect other Latin American agri‑companies.

Limited, confined to niche biotech/agri‑tech investors.

Counterpoint

Despite revenue decline, the EBITDA turnaround and debt repricing could signal a turnaround opportunity.

Key entities

  • Bioceres Crop Solutions Corp.

    Agri‑technology firm listed on NASDAQ under BIOX.

Related articles

$NVDAMedAI 8/10

Nvidia, Broadcom Just Helped Break a 90-Year Earnings Trend—Now Comes the Hard Part - State Street SPDR S

Nvidia (NVDA) and Broadcom (AVGO) reported strong Q2 earnings, with NVDA's EPS up 113.5% YoY and AVGO's up 96.4%. S&P 500 earnings grew 31%, exceeding expectations, driven by AI sector growth of 54%. This marks the first time in 90 years earnings exceeded the trend line. RIA Advisors notes two potential outcomes: sustained AI growth or normalization of profits.

$LOVEMed

Lovesac (LOVE) Target Cut by Canaccord, Analysts See 40% Upside

Canaccord cut Lovesac's (LOVE) price target to $20 but kept a Buy rating. Q2 revenue rose 0.4% YoY, with net income at $7.4M vs. a prior-year loss. Gross margin expanded to 68.4%, boosted by tariff refunds. The company lowered full-year sales and EBITDA guidance but raised net income outlook due to refunds. Analysts see 43.78% upside, with a median target of $20.

$NCLHMed

Norwegian Falls 3% as Wells Fargo Trims Carnival Target on Caribbean Pricing Pressure; Carnival Slips, Royal Caribbean Dips

Wells Fargo cut Carnival's (CCL) price target to $36 due to Caribbean pricing pressure. Norwegian (NCLH) fell 3% to $14.28, worse than Carnival's 2% drop, as it faces higher fuel costs and lower guidance. Royal Caribbean (RCL) declined 2% to $250.98. Norwegian's Q3 net yield is expected to decline 9%, and its 2026 EPS guidance was reduced to $1.50.

$NVDAMedAI 8/10

Nvidia’s Jensen Huang Stands Firm on $4 Trillion AI Bet as Critics Sound Alarms

Nvidia CEO Jensen Huang reaffirmed his forecast of a $3 trillion to $4 trillion AI infrastructure market by 2030, citing strong demand and supply constraints. Nvidia reported $96.2 billion in revenue, exceeding expectations, with data-center sales at $89 billion. Despite warnings from AI leaders about unchecked progress, Huang remains optimistic, pointing to Nvidia's dominant position in the AI sector. Shares slipped Monday amid broader chip stock declines.

$PLAYHighAI 8/10

Why Dave & Buster's (PLAY) Stock Is Nosediving

Dave & Buster's (PLAY) stock fell 11.1% after Q2 earnings missed expectations, with revenue of $544.1M (down 2.4% YoY) and an adjusted net loss of $9.5M. Comparable store sales declined 5.0% in June but improved to -1.6% in July. The company's stock is down 59.8% YTD and 71.7% from its 52-week high.